Accelerating Breakthrough Discoveries into Medicines



BioMotiv Secures $46 Million in Funding

CLEVELAND – August 5, 2013

BioMotiv, a drug development accelerator based in Cleveland, Ohio, today announced that it has increased its total capital from investors to $46 million, adding Nationwide Mutual Insurance Company and several individual investors to its founding investors, University Hospitals of Cleveland and the Harrington Family. Nationwide Mutual Insurance Company also will appoint a representative to serve on the Board of Managers of BioMotiv.

Click to view full release